Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Argument against low price being forced by PTSC -- divy vs. buy back

RE: Argument against low price being forced by PTSC -- divy vs. buy back

posted on Jun 23, 2006 07:14AM

Yes, PTSC should buy back all that is reasonable. I believe they will do just that during the ``slower`` times.

I also like the idea of another divy. Since there are many different investor / speculator goals, it makes sense to capture as many strategies as possible. PTSC will never please everyone, but the more the merrier.

IMO, one hurdle would be when / if institutional speculators get into the game in a big way. We have seen what a few large blocks can do to the pps, both ways. With many funds having limits on what type of specualtion can be done, PTSC is probably not on the radar screen for many, yet.

This could be a longer wait than some would like, but it could also be well worth it, IMO.

John

Share
New Message
Please login to post a reply